Home

David Lamond, Director: Quince Therapeutics QNCX Buy · Filed 23/12/14

Trade details

Type
Insider buy
Amount
$300
Shares · price
300 sh · $1.00 a share
Held after
2,279,964 sh
Trade date
23/12/12
Filed
23/12/14
Days to filing
2 days

Holdings up under 0.1%

Insiders buying this week
1 insiders
Holding change
under 0.1%

Quince Therapeutics trades, last 26 weeks

What else happened in Quince Therapeutics around then

Filed or reported within 30 days of the trade day · 23/11/12~24/01/11

David Lamond's recent trades

  • David Lamond

    BuyQuince Therapeutics

    $23.5K

    Filed 23/12/14

  • David Lamond

    BuyQuince Therapeutics

    $22.8K

    Filed 23/12/14

  • David Lamond

    BuyQuince Therapeutics

    $22.6K

    Filed 23/12/14

  • David Lamond

    BuyQuince Therapeutics

    $19.5K

    Filed 23/12/07

  • David Lamond

    BuyQuince Therapeutics

    $19.3K

    Filed 23/12/07

David Lamond, Director — bought $300 of Quince Therapeutics QNCX · 300 sh @ $1.00 | Whalegun